Roivant Sciences Ltd.
ROIV· Nasdaq
ROIVRoivant Sciences Ltd.
Quarterly figures for Roivant Sciences Ltd., with source filings when available.
25 quarters. Jun 30, 2020 to Jun 30, 2026. USD.
Roivant Sciences Ltd. has filed its 10-Q within 37 to 44 days of period end across its last 8 quarters. The 10-K runs 50 to 89 days.
Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q1 2026 | Jun 30, 2026 | Aug 6, 2026 · market hours | Aug 6, 2026 | 37 d | 10-Q | $1.44M | −33.5% | -$0.26 | |
| Q4 2025derived | Mar 31, 2026 | May 20, 2026 · market hours | May 20, 2026 | 50 d | 10-K | $2.52M | −66.7% | — |
|---|
| Q3 2025 | Dec 31, 2025 | Feb 6, 2026 · market hours | Feb 6, 2026 | 37 d | 10-Q | $2.00M | −77.8% | -$0.38 |
|---|
| Q2 2025 | Sep 30, 2025 | Nov 10, 2025 · market hours | Nov 10, 2025 | 41 d | 10-Q | $1.57M | −64.9% | -$0.17 |
|---|
| Q1 2025 | Jun 30, 2025 | Aug 11, 2025 · market hours | Aug 11, 2025 | 42 d | 10-Q | $2.17M | −72.8% | -$0.33 |
|---|
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Mar 31, 2025 | May 29, 2025 · market hours | May 29, 2025 | 59 d | 10-K | $7.57M | — | — | |
| Q3 2024 | Dec 31, 2024 | Feb 10, 2025 · market hours | Feb 10, 2025 | 41 d | 10-Q | $9.02M | −42.1% | $0.23 | |
| Q2 2024 | Sep 30, 2024 | Nov 12, 2024 · market hours | Nov 12, 2024 | 43 d | 10-Q | $4.48M | +22.7% | -$0.31 | |
| Q1 2024 | Jun 30, 2024 | Aug 8, 2024 · market hours | Aug 9, 2024 | 40 d | 10-Q | $7.99M | −63.1% | $0.12 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Mar 31, 2024 | May 30, 2024 · market hours | May 30, 2024 | 60 d | 10-K | — | — | — | |
| Q3 2023 | Dec 31, 2023 | Feb 13, 2024 · market hours | Feb 13, 2024 | 44 d | 10-Q | $15.56M | −8.7% | $6.03 | |
| Q2 2023 | Sep 30, 2023 | Nov 13, 2023 · market hours | Nov 13, 2023 | 44 d | 10-Q | $3.65M | −70.9% | -$0.40 | |
| Q1 2023 | Jun 30, 2023 | Aug 14, 2023 · market hours | Aug 14, 2023 | 45 d | 10-Q | $21.62M | +400.7% | -$0.38 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Mar 31, 2023 | Jun 28, 2023 · market hours | Jun 28, 2023 | 89 d | 10-K | — | — | — | |
| Q3 2022 | Dec 31, 2022 | Feb 13, 2023 · market hours | Feb 13, 2023 | 44 d | 10-Q | $17.05M | −29.9% | -$0.49 | |
| Q2 2022 | Sep 30, 2022 | Nov 14, 2022 · market hours | Nov 14, 2022 | 45 d | 10-Q | $12.53M | −10.4% | -$0.42 | |
| Q1 2022 | Jun 30, 2022 | Aug 15, 2022 · market hours | Aug 15, 2022 | 46 d | 10-Q | $4.32M | −44.2% | -$0.48 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Mar 31, 2022 | Jun 28, 2022 · market hours | Jun 28, 2022 | 89 d | 10-K | $9.22M | −39.1% | — | |
| Q3 2021 | Dec 31, 2021 | Feb 14, 2022 · market hours | Feb 14, 2022 | 45 d | 10-Q | $24.34M | +323.3% | -$0.41 | |
| Q2 2021 | Sep 30, 2021 | Nov 15, 2021 · market hours | Nov 15, 2021 | 46 d | 10-Q | $13.99M | +957.2% | -$0.32 | |
| Q1 2021 | Jun 30, 2021 | Sep 21, 2021 · after-hours | Sep 21, 2021 | 83 d | 10-Q | $7.74M | +390.8% | -$0.13 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Mar 31, 2021 | — | — | — | — | $15.15M | — | — | |
| Q3 2020 | Dec 31, 2020 | — | — | — | — | $5.75M | — | -$0.41 | |
| Q2 2020 | Sep 30, 2020 | — | — | — | — | $1.32M | — | -$0.06 | |
| Q1 2020 | Jun 30, 2020 | — | — | — | — | $1.58M | — | -$0.02 | |
